Phase I, Dose Finding Trial of the Combination of Panobinostat and Stereotactic Radiation in the Treatment of Brain Tumors.

Trial Profile

Phase I, Dose Finding Trial of the Combination of Panobinostat and Stereotactic Radiation in the Treatment of Brain Tumors.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs Panobinostat (Primary)
  • Indications Brain metastases; Glioma; Meningioma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 19 Oct 2016 Status changed from active, no longer recruiting to discontinued as Arm A reached goal and Arm B due to poor accrual.
    • 10 Feb 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2016, according to ClinicalTrials.gov record.
    • 21 Nov 2014 Results presented at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top